EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review

Santina Conte iD, Sarah Ghezelbash, Bonika Nallanathan, Philippe Lefrançois iD

Current Oncology · 13.11.2023 · 30 (11) · 9906-9928

DOI: 10.3390/curroncol30110720 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Current Oncology, online erschienen am 13.11.2023. Verfasst von Santina Conte und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terry Fox Research Institute, Fonds de Recherche du Québec - Santé, Cancer Research Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Basal cell carcinoma (BCC) is the most common skin cancer, with a lifetime risk currently approaching up to 40% in Caucasians. Among these, some clinical and pathological BCC variants pose a higher risk due to their more aggressive biological behavior. Morpheaform BCC (morBCC), also known as sclerosing, fibrosing, or morpheic BCC, represents up to 5–10% of all BCC. Overall, morBCC carries a poorer prognosis due to late presentation, local tissue destruction, tumor recurrence, and higher frequency of metastasis. In this systematic review, we review the epidemiological, clinical, morphological, dermatoscopical, and molecular features of morBCC. After the title and abstract screening of 222 studies and the full-text review of 84 studies, a total of 54 studies met the inclusion criteria and were thus included in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaSkin NeoplasmsHumansNeoplasm Recurrence, LocalTranscription Factors

Stichwörter der Autor:innen

BCCfibrosing basal cell carcinomamorpheaform basal cell carcinomamorphoeic basal cell carcinomasclerosing basal cell carcinomaskin cancer

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
  • Cancer Axis, Lady Davis Institute for Medical Research, Montreal, QC H3T 1E2, Canada.
  • Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
  • Division of Dermatology, Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
  • Division of Dermatology, Department of Medicine, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.

ORCID-Profile: Santina Conte, Philippe Lefrançois

Förderung

  • Terry Fox Research Institute
  • Fonds de Recherche du Québec - Santé
  • Cancer Research Society
  • Lady Davis Institute for Medical Research
  • Jewish General Hospital Foundation (Carole & Myer Bick, Kramer family)
  • Jewish General Hospital Department of Medicine
  • Fonds de recherche du Québec—Santé
  • Marathon of Hope Cancer Centre Network—Terry Fox Research Institute

Zitieren

APA

Conte, S., Ghezelbash, S., Nallanathan, B., & Lefrançois, P. (2023). Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review. Current Oncology, 30(11), 9906-9928. https://doi.org/10.3390/curroncol30110720

Vancouver

Conte S, Ghezelbash S, Nallanathan B, Lefrançois P. Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review. Current Oncology. 2023;30(11):9906-9928. doi:10.3390/curroncol30110720

BibTeX
@article{Conte2023,
  author = {Conte, Santina and Ghezelbash, Sarah and Nallanathan, Bonika and Lefrançois, Philippe},
  title = {Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review},
  journal = {Current Oncology},
  year = {2023},
  volume = {30},
  number = {11},
  pages = {9906--9928},
  doi = {10.3390/curroncol30110720}
}
Kostenlos starten →